In contrast, it has been reported that β-arrestin deficiency increases the sensitivity of glioma cells to treatment with NK-1R antagonists and is essential for NK1-mediated glioblastoma cell proliferation [27]. The gene discussed is TACR1; the disease is central nervous system cancer.